Thoroughbred Financial Services’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.44M Buy
22,336
+629
+3% +$44.3K 0.09% 225
2025
Q4
$1.46M Buy
21,707
+717
+3% +$48.2K 0.09% 215
2025
Q3
$1.54M Sell
20,990
-150
-0.7% -$9.96K 0.1% 203
2025
Q2
$1.1M Buy
+21,140
New +$1.2M 0.08% 247

Other funds holding HALO

Thoroughbred Financial Services's HALO Position: Q1 2026 in Review

Thoroughbred Financial Services increased its Halozyme (HALO) stake by 2.9% in Q1 2026, buying an estimated $44.3K and bringing the position to 22,336 shares worth $1.44M. The position accounts for 0.09% of the portfolio, ranked #225.

Thoroughbred Financial Services first reported a position in HALO in Q2 2025 and has held it in 4 quarters since. The position peaked at $1.54M in Q3 2025. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Thoroughbred Financial Services held 22,336 shares of Halozyme worth $1.44M as of Q1 2026.
  • Thoroughbred Financial Services bought 629 Halozyme shares in Q1 2026, an estimated $44.3K.
  • Halozyme made up 0.09% of Thoroughbred Financial Services's portfolio in Q1 2026, its #225 holding.
  • Thoroughbred Financial Services first reported a position in Halozyme in Q2 2025 and has held it in 4 quarters since.
  • Thoroughbred Financial Services's Halozyme position peaked at $1.54M in Q3 2025.
  • 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Thoroughbred Financial Services's 13F filing for Q1 2026, filed 12 May 2026.